Hemochromatosis after the gene discovery: Revisiting the diagnostic strategy

Journal of Hepatology, Supplement

Volumn 28, Issue 1, 1998, Pages 14-18

  Brissot, Pierre ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CYSTEINE; FERRITIN; HISTIDINE; IRON; TRANSFERRIN; TYROSINE;

CHROMOSOME 6P; GENE MUTATION; GENETIC ANALYSIS; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON METABOLISM; LIVER BIOPSY; MASS SCREENING; PRIORITY JOURNAL; REVIEW;

CHROMOSOMES, HUMAN, PAIR 6; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MEMBRANE PROTEINS; MUTATION;

EID: 0031982042     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
2. Jouanolle AM, Gandon, G, Jézéquel P, Blayau M, Campion ML, Yaouanq J, et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14: 251-2.
3. Brissot P, Moirand R, Jouanolle AM, Guyader D, Le Gall JY, Deugnier Y, et al. A genotypic study of 207 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. Hepatology 1997; 26: 370A.
4. Merryweather-Clarke A, Pointon JJ, Shearman JD, Robson. KJH. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-8.
5. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14: 249-51.
6. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in hereditary hemochromatosis: evolution of diagnostic criteria. Hepatology 1997; 26: 199A.
7. Borot N, Roth MP, Malfroy L, Demangel C, Vinel JP, Pascal JP, et al. Mutations in the MCH class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997; 45: 320-4.
8. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997; 60: 828-32.
9. Barton JC, Shih WWH, Sawada-Hirai R, Acton RT, Harmon L, Rivers C, et al. Genetic and clinical description of hemochromatosis probands and hétérozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis 1997; 23: 135-45.
10. Moirand R, Jouanolle AM, Deugnier Y, Brissot P, Le Gall JY, David V. Correlations between body iron stores and HLA-H mutations in patients with iron overload. Hepatology 1997; 26: 370A.
11. Brissot P, Deugnier Y. Haemochromatosis. In: Mclntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, in press.
12. Moirand R, Adams P, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared to men. Ann Intern Med 1997; 127: 105-10.
13. Adams PC, Deugnier, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997; 25: 162-6.
14. Brissot P, Pigeon C, Moirand R, Guyader D, Mendier MH, Sapey T, et al. Le métabolisme du fer et son exploration en biologie clinique. Ann Biol Clin: in press.
15. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993; 328: 1616-20.
16. Edwards CQ, Griffen LM, Kaplan J, Kushner JP. Twentyfour hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes. J Intern Med 1989; 226: 373
17. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996; 335: 1799805.
18. Brissot P, Deugnier Y, Le Treut A, Regnouard F, Simon M, Bourel M. Ascorbic acid status in idiopathic hemochromatosis. Digestion 1978; 17: 479-87.
19. Custer EM, Finch CA, Sobel RE, Zettner A. Population norms for serum ferritin. J Lab Clin Med 1995; 126: 88-94.
20. Roeser HP. The role of ascorbic acid in the turnover of storage iron. Semin Hematol 1983; 20: 91-100.
21. Guyader D, Moirand R, Jacqueline! C, Adams P, Turlin B, David V, et al. Prédiction de la cirrhose hépatique chez les patients ayant une hémochromatose homozygote C282Y. Implications concernant les indications de la biopsie hépatique. Communication, Journées Francophones de Pathologie Digestive, Paris 21-25 March 1998. Gastroentérol Clin Biol, ré sumé: in press.
22. Moirand R, Mortaji A, Loréal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997; 349: 95-7.
23. Yoshida K, Furihata K, Takeda S, Nakamura A, Yamamoto K, Morita H, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 1995; 9: 267-72.
24. Moirand R, Lescoat G, Delamaire D, Loréal O, Deugnier Y, Brissot P. Increase of glycosylated and non-glycosylated serum ferritin in chronic alcoholism and evolution during alcohol withdrawal. Alcohol Clin Exp Res 1991; 15: 963-9.
25. Moirand R, Kerdavid F, Loréal O, Hubert N, Leroyer P, Brissot P, et al. Regulation of ferritin expression by alcohol in a human hepatoblastoma cell line and in rat hepatocyte cultures. J Hepatol 1995; 23: 431-9.
26. Beutler E. Gaucher disease. Blood Rev 1988; 2: 59-70.
27. Laine F, Guyader D, Turlin B, Moirand R, Deugnier Y, Brissot'P. Hyperferritinémie et maladie de Gaucher. Gastroentérol Clin Biol 1996; 20: 512-3.
28. Girelli D, Olivieri O, De Franceschi L, Corrocher R, Bergamaschi G. A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. Br J Haematol 1995; 90: 931-4.
29. Beaumont C, Leneuve P, Devaux I, Scoazec JY, Berthier M, Loiseau MN, et al. Mutation in .the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nat Genet 1995; 11: 444-6.
30. Deugnier Y, Loréal O, Turlin B, Guyader D, Jouanolle H, Moirand R, et al. Liver pathology in genetic hemqchromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992; 102: 2050-9. .
31. Deugnier Y, Turlin B, Powell LW, Summers K, Moirand R,' . Fletcher L, et al. Differentiation between hétérozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 1993; 17: 30-4.
32. Brissot P, Bourel M, Kerry D, Verger JP, Messner M, Beaumont C, et al. Assessment of liver iron content in 271 patients: a réévaluation of direct and indirect methods. Gastroenterology 1981; 80: 557-65. . "
33. Olynyk JK, O'Neill R, Britton RS, Bacon BR. Determination of hepatic iron concentration in fresh and paraffinembedded tissue: diagnostic implications. Gastroenterology 1994; 106: 674-7.
34. Villeneuve JP, Bilodeau M, Lepage R, Côté J, Lefebvre M. Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 1996; 25: 172-7.
35. Ludwig J, Hashimoto E, Porayko MK, Mover TP, Baldus W. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997; 112: 882-8.
36. Deugnier Y, Turlin B, Le Quilleuc D, Moirand R, Loréal O, Messner M, et al. A reappraisal of liver siderosis in patients with end-stage cirrhosis: practical implications in the diagnosis hemochromatosis. Am J Surg Pathol 1997; 21: 669-75.
37. Deugnier Y, Charalambous P, Le Quilleuc D, Turlin B, Searle J, Brissot P, et al. Preneoplastic significance of hepatic ironfree foci in genetic hemochromatosis: a study of 185 patients. Hepatology 1993; 18: 1363-9.
38. Loréal O, Deugnier Y, Moirand R, Lauvin L, Guyader D, Jouanolle H, et al. Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients. J Hepatol 1992; 16: 122-7.
39. Adams PC, Campion ML, Gandon G, LeGall JY, David V, Jouanolle AM. Clinical and family studies in genetic hemochromatosis: microsatellite and HFE studies in five atypical families. Hepatology 1997; 26: 986-90.
40. Cullen LM, Summerville L, Glassick TV, Crawford DH, Powell LW, Jazwinska EC. Neonatal screening for the hemochromatosis defect. Blood 1998: 90: 4236-7.
41. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of-the haemochromatosis C282Y mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-3.